SLC6A3 and supranuclear palsy, progressive, 1: Compared with PD and MSA, PSP is characterized by the most pronounced loss of DAT function at both caudate and putamen; in addition, caudate DAT binding is lower in patients with MSA than in those with PD (Kaasinen et al., 2019).